CD4 and type 1 diabetes mellitus: These findings suggest that dysregulated activity of key transcriptional regulators, particularly PRDM1 and GATA3, may contribute to the altered gene expression landscapes in specific CD4+ Tcell subsets during early type 1 diabetes development.